Vertilmicin Sulfate
| Code | Size | Price |
|---|
| TAR-T29105-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Vertilmicin Sulfate, an aminoglycoside antibiotic, is used potentially for the treatment of bacterial infections.
CAS:
857468-21-4
Formula:
C44H96N10O34S5
Molecular Weight:
1469.59
Purity:
0.98
SMILES:
OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(=CC[C@H]2N)C(C)N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(=CC[C@H]2N)C(C)N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O
References
1. Yuan YZ, Zhang M, Fan XL, Hu CQ, Jin SH, Van Schepdael A, Hoogmartens J, Adams E. Analysis of impurities in vertilmicin sulfate by liquid chromatography ion-trap mass spectrometry. J Pharm Biomed Anal. 2013 Jun;80:1-8. doi: 10.1016/j.jpba.2013.02.026. PubMed PMID: 23518304.
2. Wang J, Wang D, He H, Ni K. Determination of vertilmicin sulfate and its related substances by HPLC-ELSD and HPLC-MS2. J Chromatogr Sci. 2006 Oct;44(9):529-34. PubMed PMID: 17059677.
3. Liu Z, Duan G. Stability indicating reversed-phase ion-pairing liquid chromatographic determination of vertilmicin sulfate as bulk drug and in injections. J Pharm Biomed Anal. 2005 Mar 9;37(3):577-83. PubMed PMID: 15740919.
4. Huang TM, Deng CH, Chen NZ, Liu Z, Duan GL. High performance liquid chromatography for the determination of glucosamine sulfate in human plasma after derivatization with 9-fluorenylmethyl chloroformate. J Sep Sci. 2006 Oct;29(15):2296-302. PubMed PMID: 17120813.